MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII-Reference-Cited by-同舟云学术

MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII

Published:2023-01 Issue: Volume:187 Page:106606
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Tong Fei,Zhao Ji-xing,Fang Zi-yuan,Cui Xiao-teng,Su Dong-yuan,Liu Xing,Zhou Jun-hu,Wang Guang-xiu,Qiu Zhi-jun,Liu Shi-zhong,Fu Jun-qi,Kang Chun-sheng,Wang Jia-chong,Wang Qi-xue

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. Bright Future for Novel Viral Glioblastoma Multiforme Therapy;McCarthy;World Neurosurg.,2018

2. The somatic genomic landscape of glioblastoma;Brennan;Cell,2013

3. The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR;Luwor;Oncogene,2004

4. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies;An;Oncogene,2018

5. Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas;Wang;Aging,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MUC1andMUC4expression are inversely correlated and trigger immunological response and transport pathways in gliomas;2024-06-30

2. Revolutionizing Brain Tumor Care: Emerging Technologies and Strategies;Biomedicines;2024-06-20

3. Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening;International Journal of Molecular Sciences;2024-05-23

4. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas;Genes;2024-04-11

5. Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology;Trends in Cancer;2024-04